Ligand validation:2Z9W

PXL: 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE

PXL is a Ligand Of Interest in 2Z9W designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Z9W_PXL_B_1197	90%	39%	0.073	0.955	0.81	1.54	1	4	1	0	100%	0.9167
2Z9W_PXL_A_1197	88%	48%	0.081	0.956	0.88	1.11	-	1	0	0	100%	0.9167
2Z9X_PXL_A_1503	93%	31%	0.071	0.981	1.11	1.62	1	1	0	0	92%	0.9167
4C5N_PXL_C_300	81%	44%	0.089	0.942	0.93	1.22	-	1	2	0	100%	1
1TD2_PXL_B_289	79%	8%	0.116	0.963	3.13	1.58	7	4	2	0	100%	1
3MBH_PXL_C_400	70%	4%	0.129	0.946	3.21	2.36	3	6	0	0	100%	1
4C5L_PXL_B_300	53%	13%	0.169	0.932	1.47	2.44	3	4	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.